CHARGE association in Sweden: malformations and functional deficits

Kerstin Strömland1, Lotta Sjögreen, Maria Johansson

  • 1Department of Ophthalmology, Sahlgrenska University Hospital, Göteborg, Sweden. kerstin.stromland@vgregion.se

Insights

CHARGE association (CA) is a genetic disorder affecting multiple body systems. This study highlights frequent physical abnormalities, sensory impairments, and developmental delays in Swedish patients, emphasizing early pregnancy as a critical maldevelopment period.

Area of Science:

  • Genetics
  • Pediatrics
  • Developmental Biology

Background:

  • CHARGE association (CA) is a complex genetic disorder characterized by a specific set of malformations.
  • Understanding the full spectrum of CA and its etiology is crucial for patient management.

Purpose of the Study:

  • To describe associated malformations and functional deficits in Swedish patients with CA.
  • To investigate potential etiological factors and critical developmental time periods.
  • To emphasize the need for a multidisciplinary approach in managing CA.

Main Methods:

  • Prospective multidisciplinary study of 31 Swedish patients with CA.
  • Analysis of clinical files and maternal questionnaires on prenatal events.
  • Comprehensive clinical evaluations of systemic, sensory, and neuro-psychiatric functions.

Main Results:

  • High prevalence of ear (90%) and eye (90%) anomalies, brain (61%) and heart (52%) defects, growth retardation (48%), genital (38%), and choanal (35%) issues.
  • Significant visual impairment (61%) and hearing loss (74%) were common.
  • Developmental delay (82%), autism (40%), and functional deficits in balance, speech, and eating were prevalent.
  • Malformations likely occurred early in pregnancy (weeks 4-6).

Conclusions:

  • CHARGE association presents with a wide range of physical and functional impairments.
  • Early pregnancy (weeks 4-6) is a critical period for maldevelopment in CA.
  • Multidisciplinary assessment and management are essential for individuals with CHARGE association.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...